Legal Representation
Attorney
Christopher N. Bolinger
USPTO Deadlines
Application History
10 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 4, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Jun 1, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Sep 26, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Jul 4, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jun 14, 2006 | NPUB | O | NOTICE OF PUBLICATION |
May 23, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
May 12, 2006 | ALIE | A | ASSIGNED TO LIE |
May 10, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
May 10, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Dec 20, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005